Carlos L. Arteaga, MD
Professor of Medicine Director, UTSW Harold C. Simmons Comprehensive Cancer Center The Lisa K. Simmons Distinguished Chair in Comprehensive Oncology Associate Dean of Oncology Programs, Dallas, TX
Dr. Arteaga obtained his MD degree at the University of Guayaquil in Ecuador. He trained in Internal Medicine and Medical Oncology at Emory University and the University of Texas Health Sciences Center San Antonio, respectively. He joined Vanderbilt in 1989 where he served as Associate Director for Translational/Clinical Research, Director of the Center for Cancer Targeted Therapies and the Breast Cancer Program of the Vanderbilt-Ingram Cancer Center (VICC). He has over 300 publications in the areas of signaling by growth factor receptors and oncogenes in breast tumor cells, development of targeted therapies and biomarkers of drug action and resistance, and investigator-initiated clinical trials in breast cancer. Since 2002, he directed the NCI-funded Vanderbilt Breast Cancer SPORE where he co-led several investigator-initiated clinical trials. His research is or has been funded by the National Cancer Institute, the American Cancer Society, the Department of Defense Breast Cancer Research Program, Stand Up 2 Cancer (SU2C), the Susan G. Komen for the Cure Foundation, and the Breast Cancer Research Foundation. He served in the NCI Board of Scientific Counselors (1999-2004), NCI Parent Subcommittee A for review of Cancer Centers (2004-2008), the Breast Core Committee of the Eastern Cooperative Oncology Group (ECOG) and the Board of Directors of the American Association for Cancer Research (2004-2007). Arteaga is the recipient of the 2003 AACR Richard & Hinda Rosenthal Award, a 2007-2017 ACS Clinical Research Professor Award, the 2009 Gianni Bonadonna Award from the American Society of Clinical Oncology (ASCO), the 2011 Brinker Award for Scientific Distinction from the Komen Foundation, and the 2015 Prize for Scientific Excellence in Medicine from the American-Italian Cancer Foundation.